|
SHIMIZU Kyoko
Department Other, Other Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial |
| Journal | Formal name：Annals of oncology : official journal of the European Society for Medical Oncology / ESMO Abbreviation：Ann Oncol ISSN code：09237534/15698041 |
| Domestic / Foregin | Foregin |
| Publisher | Oxford University Press on behalf of the European Society for Medical Oncology. |
| Volume, Issue, Page | 30(12),pp.1950-1958 |
| Author and coauthor | C. Morizane, T. Okusaka, J. Mizusawa, H. Katayama, M. Ueno, M. Ikeda, M. Ozaka, N. Okano,
K. Sugimori, A. Fukutomi, H. Hara, N. Mizuno, H. Yanagimoto, K. Wada, K. Tobimatsu, K. Yane, S. Nakamori, H. Yamaguchi, A. Asagi, S. Yukisawa, Y. Kojima, K. Kawabe, Y. Kawamoto, R. Sugimoto, T. Iwai, K. Nakamura, H. Miyakawa, T. Yamashita, A. Hosokawa, T. Ioka, N. Kato, K. Shioji, K. Shimizu, T. Nakagohri, K. Kamata, H. Ishii & J. Furuse, on behalf of the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG) |
| Publication date | 2019/12 |
| DOI | 10.1093/annonc/mdz402 |